It’s a “Three-Peat”: FDA Approves LEQSELVI (Deuruxolitinib) for the Treatment of Severe AA
The U.S. Food and Drug Administration (FDA) approved Sun Pharma’s LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata (AA). LEQSELVI is a new, twice-daily oral selective inhibitor of Janus Kinases (JAK) JAK1 and JAK2. As a JAK inhibitor, LEQSELVI interrupts the pathways thought to contribute to hair loss in […]